Atara Biotherapeutics
ATRA
ATRA
82 hedge funds and large institutions have $57.9M invested in Atara Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 24 closing their positions.
Holders
82
Holders Change
-8
Holders Change %
-8.89%
% of All Funds
1.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
27
Reduced
28
Closed
24
Calls
$33K
Puts
$39K
Net Calls
-$6K
Net Calls Change
-$2K
Top Buyers
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$73.9K |
| 2 |
2
Millennium Management
New York
|
$251K |
| 3 |
3
Morgan Stanley
New York
|
$934K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$3.48M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$938K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Simplex Trading
Chicago,
Illinois
| – | – | -257 | Closed |
|
102
Federated Hermes
Pittsburgh,
Pennsylvania
| – | – | -19 | Closed |
|
103
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | – | -16 | Closed |
|
|
NC
104
NewSquare Capital
Newtown Square,
Pennsylvania
| – | – | -2 | Closed |
|
105
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | – | -2 | Closed |
|
|
CFGS
106
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
CAL
107
Capital Advisors Ltd
Shaker Heights,
Ohio
| $0 | 16 | +16 | New |
|